melatonin and epirubicin

melatonin has been researched along with epirubicin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	1 (16.67)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Barni, S; Crispino, S; Esposti, D; Esposti, G; Ferri, L; Fumagalli, G; Lissoni, P; Paolorossi, F; Rovelli, F; Tancini, G	1
Ardizzoia, A; Barni, S; Giani, L; Lissoni, P; Malugani, F; Mandalà, M; Paolorossi, F; Tancini, G	1
Bukan, N; Cam, M; Comunoglu, C; Ercan, F; Guven, A; Yavuz, O	1
Chen, ZJ; Li, H; Li, N; Wang, N; Zhang, C; Zhu, Y	1

Trials

1 trial(s) available for melatonin and epirubicin

Article	Year
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study. Journal of pineal research, 1999, Volume: 26, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Melatonin; Middle Aged; Platelet Count; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome	1999

Article

Year

Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study.

Journal of pineal research, 1999, Volume: 26, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Melatonin; Middle Aged; Platelet Count; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome

1999

Other Studies

5 other study(ies) available for melatonin and epirubicin

Article	Year
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Acute effects of various chemotherapeutic combinations on hypophyseal and pineal hormone secretions in cancer patients. Tumori, 1987, Apr-30, Volume: 73, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; beta-Endorphin; Cisplatin; Cyclophosphamide; Doxorubicin; Endorphins; Epirubicin; Female; Fluorouracil; Humans; Hydrocortisone; Male; Melatonin; Methotrexate; Neoplasms; Pineal Gland; Pituitary Gland, Anterior; Pituitary Hormones, Anterior; Secretory Rate; Vincristine	1987
Melatonin protects against epirubicin-induced cardiotoxicity. Acta histochemica, 2007, Volume: 109, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Drug Therapy, Combination; Epirubicin; Extracellular Matrix Proteins; Glutathione; Heart Diseases; Immunoenzyme Techniques; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Myocytes, Cardiac; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Wistar	2007
Melatonin protects against Epirubicin-induced ovarian damage. The Journal of reproduction and development, 2020, Feb-14, Volume: 66, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Body Weight; Caspase 3; Caspase 9; Endoplasmic Reticulum Stress; Epirubicin; Estradiol; Female; Melatonin; Mice; Mice, Inbred ICR; Ovary; Oxidative Stress; Progesterone; Protective Agents; Reactive Oxygen Species; Uterus	2020